tiprankstipranks

John P. Hamill Insider Profile

11 Followers
John P. Hamill, SrVP/CFO/Prin Fin & Acct Ofcr at Aprea Therapeutics, holds 43.53K shares in Aprea Therapeutics (Ticker: APRE), holds ― shares in Cellectar Biosciences (Ticker: CLRB), holds 72.80K shares in Windtree Therapeutics (Ticker: WINT).
tipranks
John P. Hamill

John P. Hamill
Aprea Therapeutics (APRE)
SrVP/CFO/Prin Fin & Acct Ofcr

Ranked #103,354 out of 109,030 Corporate Insiders

Profitable Transactions

20%
2 out of 10 Profitable Transactions

Average Return

-41.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$35K
94.98%
2.55%
2.47%
0.00%
A breakdown of John P. Hamill's holdings

Insider Roles

Aprea Therapeutics
(APRE)
SrVP/CFO/Prin Fin & Acct Ofcr
Trevena
(TRVN)
VP Fin,Princ Fin&Acct Officer
Windtree Therapeutics
(WINT)
SVP & CFO
Cellectar Biosciences
(CLRB)
Interim CFO
Roles that John P. Hamill holds in companies

Most Profitable Insider Trade

Stock:
Trevena
(TRVN)
Rating:Informative Buy
Date:Jun 04, 2019 - Jun 04, 2020
Return:+19.80%
The most profitable trade made by John P. Hamill

John P. Hamill's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Aprea Therapeutics
Mar 16, 2026
SrVP/CFO/Prin Fin & Acct Ofcr
Uninformative Buy
$33.65K
Cellectar Biosciences
Interim CFO
Trevena
Jun 04, 2019
VP Fin,Princ Fin&Acct Officer
Informative Buy
8.70K
$904.57
Windtree Therapeutics
Jul 26, 2022
SVP & CFO
Informative Buy
1.08K
$873.60
List of latest transactions for each holding click on a transaction to see John P. Hamill's performance on stock

John P. Hamill insider profile FAQ

What is the percentage of profitable transactions made by John P. Hamill?
The percentage of profitable transactions made by John P. Hamill is 20%.
    What is the average return per transaction made by John P. Hamill?
    The average return per transaction made by John P. Hamill is -41.90%.
      What stocks does John P. Hamill hold?
      John P. Hamill holds: APRE, CLRB, TRVN, WINT stocks.
        What was John P. Hamill’s latest transaction?
        John P. Hamill latest transaction was an Uninformative Buy of ―.
          What was John P. Hamill's most profitable transaction?
          John P. Hamill’s most profitable transaction was an Informative Buy of TRVN stock on June 4, 2019. The return on the trade was 19.80%.
            What is John P. Hamill's role in Aprea Therapeutics?
            John P. Hamill's role in Aprea Therapeutics is SrVP/CFO/Prin Fin & Acct Ofcr.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.